Immunoproteome of Aspergillus fumigatus Using Sera of Patients with Invasive Aspergillosis
出版年份 2014 全文链接
标题
Immunoproteome of Aspergillus fumigatus Using Sera of Patients with Invasive Aspergillosis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 15, Issue 8, Pages 14505-14530
出版商
MDPI AG
发表日期
2014-08-20
DOI
10.3390/ijms150814505
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations in the Chromodomain-like Insertion of Translation Elongation Factor 3 Compromise Protein Synthesis through Reduced ATPase Activity
- (2013) Arjun N. Sasikumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunoproteomics based identification of thioredoxin reductase GliT and novel Aspergillus fumigatus antigens for serologic diagnosis of invasive aspergillosis
- (2012) Li-ning Shi et al. BMC MICROBIOLOGY
- Invasive fungal infections in patients with cancer in the Intensive Care Unit
- (2012) Nikolaos V. Sipsas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible for false-positive results of the galactomannan assay
- (2012) M. Mikulska et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Differential proteomic analysis of Aspergillus fumigatus morphotypes reveals putative drug targets
- (2012) Paula H. Kubitschek-Barreira et al. Journal of Proteomics
- Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole
- (2011) Saskia Kuipers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cross-Reactivity of Fusarium spp. in the Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay
- (2011) A. M. Tortorano et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Identification of virulence factors and diagnostic markers using immunosecretome of Aspergillus fumigatus
- (2011) Awanit Kumar et al. Journal of Proteomics
- Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
- (2010) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cytochrome P450 enzymes in the fungal kingdom
- (2010) B. Črešnar et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Analysis of the cellular Aspergillus fumigatus proteome that reacts with sera from rabbits developing an acquired immunity after experimental aspergillosis
- (2010) Abdul R. Asif et al. ELECTROPHORESIS
- Immuno-Reactive Molecules Identified from the Secreted Proteome ofAspergillus fumigatus
- (2010) Bharat Singh et al. JOURNAL OF PROTEOME RESEARCH
- Novel Cytosolic Allergens ofAspergillus fumigatusIdentified from Germinating Conidia
- (2010) Bharat Singh et al. JOURNAL OF PROTEOME RESEARCH
- Risk stratification for invasive aspergillosis: early assessment of host susceptibility
- (2009) Thomas F. Patterson MEDICAL MYCOLOGY
- Cross-Reactivity of Paracoccidioides brasiliensis, Histoplasma capsulatum, and Cryptococcus Species in the Commercial Platelia Aspergillus Enzyme Immunoassay
- (2008) M. O. Xavier et al. Clinical and Vaccine Immunology
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Infections Caused by Scedosporium spp.
- (2008) K. J. Cortez et al. CLINICAL MICROBIOLOGY REVIEWS
- Elongation Factor 3, EF3, Associates with the Calcium Channel Cch1 and Targets Cch1 to the Plasma Membrane inCryptococcus neoformans
- (2008) Min Liu et al. EUKARYOTIC CELL
- Proteome analysis for pathogenicity and new diagnostic markers forAspergillus fumigatus
- (2008) Olaf Kniemeyer et al. MEDICAL MYCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More